Arun V J: Is Plasma The Semiconductor Chips In Healthcare?
Arun V J, Consultant in the Department of Transfusion Medicine at Malabar Medical College, shared a post on LinkedIn:
“Is Plasma The Semiconductor Chips In Healthcare?
India has 1.4 billion people. Highest eligible donor population.
Then why do we import most of our plasma medicines?
Plasma is liquid gold.
Inside that pale yellow fluid are:
- Immunoglobulins (IVIG)
- Clotting factors (VIII, IX)
- Albumin
- Life-saving proteins for hemophilia, immune deficiencies, ICU care
Yet India still imports a large share of its plasma-derived medicines.
We have:
- More than 3,000 blood centres
- Millions of blood donations annually
- A strong pharmaceutical manufacturing ecosystem
But we also have:
- Fragmented plasma collection
- Limited large-scale fractionation capacity
- No robust national plasma pooling grid
- Regulatory limitations on source plasma
- High discard rates in some regions
Most of our plasma comes from recovered plasma (after whole blood donation).
Countries like the US rely heavily on source plasma collected via plasmapheresis – predictable, scalable, industrial.
Fractionation requires:
- Consistent volumes
- Strict freezing timelines
- GMP pharmaceutical processing
- Capital-heavy infrastructure
Without aggregation, there is no economy of scale.
Without scale, there is no viability.
Without viability, imports continue.
This is not a criticism.
If we want plasma self-reliance, the conversation must shift toward:
- National plasma pooling models
- Public–private fractionation partnerships
- Infrastructure upgrades in blood centres
- Transparent plasma utilization data
- Policy-level strategic planning
Healthcare sovereignty is not about sentiment.
It is about resilience.
During global supply disruptions, plasma imports become vulnerable.
Plasma isn’t just a blood component.
It is strategic healthcare infrastructure.
The question is not whether India can do it.
The question is whether we will build the system to do it.
If you work in transfusion medicine, healthcare policy, pharma, or hospital leadership – this deserves attention.
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 23, 2026, 22:46Gloria Duah: Not All ‘O Negative’ Blood Is Safe for Every Patient
-
Apr 23, 2026, 22:46Luke McLaughlin: Is Haemophilia a disability? – Vote or Share
-
Apr 23, 2026, 22:44Sonia Wolf: On My Way Back From a Very Invigorating BSH
-
Apr 23, 2026, 22:43Maximo Agustin Schiavone: ‘The Lower the Better’ Is Not a Physiological Principle
-
Apr 23, 2026, 18:19Chokri Ben Lamine: Choosing the Right LMWH in Cancer Patients
-
Apr 23, 2026, 17:57Shalini R: Not All Blood Thinners Are the Same
-
Apr 23, 2026, 17:33Abdulaziz (Omar) Badran: Navigating the Clinical Complexity of Combined Red Cell Disorders
-
Apr 23, 2026, 17:19Kate Thomas: One Hour, One Donation, One Life Saved
-
Apr 23, 2026, 17:19Ameneh Eshghinejad: The First 72 Hours After SAH Are Critical for Balancing the Risks of Rebleeding and Thromboembolism